These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 32283068)

  • 1. The Novel In Vitro Method to Calculate Tissue-to-Plasma Partition Coefficient in Humans for Predicting Pharmacokinetic Profiles by Physiologically-Based Pharmacokinetic Model With High Predictability.
    Mayumi K; Tachibana M; Yoshida M; Ohnishi S; Kanazu T; Hasegawa H
    J Pharm Sci; 2020 Jul; 109(7):2345-2355. PubMed ID: 32283068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
    Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
    Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions.
    Lee W; Kim MS; Kim J; Aoki Y; Sugiyama Y
    Drug Metab Dispos; 2023 Sep; 51(9):1145-1156. PubMed ID: 36914276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds.
    Mao J; Ma F; Yu J; Bruyn T; Ning M; Bowman C; Chen Y
    Biopharm Drug Dispos; 2023 Aug; 44(4):315-334. PubMed ID: 37160730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Human Pharmacokinetics of E0703, a Novel Radioprotective Agent, Using Physiologically Based Pharmacokinetic Modeling and an Interspecies Extrapolation Approach.
    Ge YX; Zhang Z; Yan JY; Ma ZC; Wang YG; Xiao CR; Zhuang XM; Gao Y
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs.
    Yuan Y; He Q; Zhang S; Li M; Tang Z; Zhu X; Jiao Z; Cai W; Xiang X
    Front Pharmacol; 2022; 13():895556. PubMed ID: 35645843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting volume of distribution with decision tree-based regression methods using predicted tissue:plasma partition coefficients.
    Freitas AA; Limbu K; Ghafourian T
    J Cheminform; 2015; 7():6. PubMed ID: 25767566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans.
    Li Y; Wang Z; Li Y; Du J; Gao X; Li Y; Lai L
    Pharm Res; 2024 Jun; ():. PubMed ID: 38918309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
    Chou WC; Lin Z
    Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.
    De Sutter PJ; Rossignol P; Breëns L; Gasthuys E; Vermeulen A
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example.
    Liang X; Koleske ML; Yang J; Lai Y
    AAPS J; 2024 Jan; 26(1):13. PubMed ID: 38182946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models.
    Zhang L; Feng F; Wang X; Liang H; Yao X; Liu D
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
    Saleh MAA; Gülave B; Campagne O; Stewart CF; Elassaiss-Schaap J; de Lange ECM
    Pharm Res; 2023 Nov; 40(11):2555-2566. PubMed ID: 37442882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling.
    Gaohua L; Zhang M; Sychterz C; Chang M; Schmidt BJ
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
    Pearce RG; Setzer RW; Davis JL; Wambaugh JF
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach.
    Ramisetty BS; Yang S; Dorlo TPC; Wang MZ
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0032824. PubMed ID: 38842325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage.
    Stoyanova R; Katzberger PM; Komissarov L; Khadhraoui A; Sach-Peltason L; Groebke Zbinden K; Schindler T; Manevski N
    J Chem Inf Model; 2023 Jan; 63(2):442-458. PubMed ID: 36595708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting human pharmacokinetics from preclinical data: volume of distribution.
    Yim DS; Choi S
    Transl Clin Pharmacol; 2020 Dec; 28(4):169-174. PubMed ID: 33425799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure.
    Pillai N; Abos A; Teutonico D; Mavroudis PD
    Clin Transl Sci; 2024 May; 17(5):e13824. PubMed ID: 38752574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs.
    Poulin P; Nicolas JM; Bouzom F
    J Pharm Sci; 2024 Jan; 113(1):118-130. PubMed ID: 37634869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.